Recent evidence suggests that underfeeding (providing 70% of energy and protein requirements) is not harmful during the acute phase of critical illness in patients in the intensive care unit.

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

CERo Therapeutics has initiated a Phase 1 clinical trial for its innovative product candidate, CER-1236, targeting acute myeloid leukemia, signifying a key milestone in its development pipeline.

This co-infection complicates the diagnosis and treatment of TB, ultimately affecting outcomes adversely. Acute-phase proteins (APPs), markers of inflammation, are significantly elevated during ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

Background: Differences exist between European and American guideline recommendations regarding targets for low-density ...

Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that ... immune response." The phase 2 trial will test a 30 ...

The aim of this study was to evaluate the usefulness in Russian general practice of CRP testing in patients with acute cough/RTI. In addition to studying the effect of CRP testing on the ...

C-reactive protein (CRP) increases rapidly in response to infection and inflammation. CRP provides a link between the innate and adaptive immune systems by activation of complement and interaction ...

eIsraeli National Hemophilia Center and Thrombosis Unit and The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer, Israel fChildren's Hospital Los Angeles, University of ...